Medical Information
United States

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

ANTIVENIN® Clinical Pharmacology (micrurus fulvius)


12.1 Mechanism of Action

North American Coral Snake Antivenin (Equine) specifically binds to and neutralizes coral snake venom.

12.2 Pharmacodynamics

North American Coral Snake Antivenin (Equine) is standardized for potency in mice in terms of its LD50 neutralizing capacity per milliliter as determined by intravenous injection of a graded series of mixtures of North American Coral Snake Antivenin (Equine) with M. f. fulvius venom. Based on this assay system, the reconstituted contents of each vial (10 mL) will neutralize approximately 250 mouse LD50 or approximately 2 mg of M.f. fulvius venom.

The results of cross-neutralization tests indicate that North American Coral Snake Antivenin (Equine) will neutralize the venom of M. fulvius tenere (Texas coral snake) but will not neutralize the venom of Micruroides euryxanthus (Arizona or Sonoran coral snake).

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event